Containing 3 - (1. H-indol-3-il) - 4 - 2 - (4-metal-piperazin-1-il) - quinazolin-4-il - quinazolin-4-il - pirol-2, 5-diona

摘要

1. It refers to the monomer pharmacological synthesis composed of 3 - (1. H-indol-3-il) - 4 - [2 - (4-met-piperazin-1-il) - quinazolin-4-il] - quinazolin-4-il] - pirol-2, 5-diona, characterized by at least one lubricating oil, such as magnesium stearate, accounting for 2-15% by weight; An additional irritant, comprising at least one polymer, a filler, a decomposer, a dispersant and a surface activity, comprises a plate,The total weight of the components is the total weight of the nucleus on the plate. It also refers to a preparation method in the pharmacological form of oral administration. This component helps to improve the consistency and stability of the active compounds.